Expression of TCF3 target genes defines a subclass of diffuse large B-cell lymphoma characterized by up-regulation of MYC target genes and poor clinical outcome following R-CHOP therapy-Reference-Cited by-同舟云学术

Expression of TCF3 target genes defines a subclass of diffuse large B-cell lymphoma characterized by up-regulation of MYC target genes and poor clinical outcome following R-CHOP therapy

Published:2022-11-06 Issue:1 Volume:64 Page:119-129
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Tyryshkin Kathrin¹²,Moore Alison¹,Good David¹,Popov Jesse³,Crocker Susan¹,Rauh Michael J.¹,Baetz Tara⁴,LeBrun David P.¹

Affiliation:

1. Department of Pathology and Molecular Medicine, Queen’s University, Kingston, Ontario, Canada

2. School of Computing, Queen’s University, Kingston, Ontario, Canada

3. Department of Internal Medicine, Queen’s University, Kingston, Ontario, Canada

4. Department of Medical Oncology, Queen’s University, Kingston, Ontario, Canada

Funder

Interdisciplinary Cancer Research Grant

Queen’s University Department of Oncology to TB and DPL

Leukemia & Lymphoma Society of Canada to DPL

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2022.2136968

Reference51 articles.

1. As the world turns, evolving lymphoma classifications–past, present and future

2. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001

3. Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study

4. Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20+B-Cell Lymphoma in the Rituximab Era

5. Transferring genomics to the clinic: distinguishing Burkitt and diffuse large B cell lymphomas